Briacell Therapeutics Corp (BCTX) — Long-term Investment Intensity
Briacell Therapeutics Corp (BCTX) has a Long-term Investment Intensity of 2.8% as of April 2026. Long-term investments of $750.98K represent 2.8% of total assets of $27.07 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See BCTX net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Briacell Therapeutics Corp Long-term Investment Intensity (2017–2024)
This chart shows how Briacell Therapeutics Corp's Long-term Investment Intensity has evolved across 8 annual periods from 2017 to 2024. As of April 2026, the intensity stands at 2.8%, reflecting long-term investments of $750.98K against total assets of $27.07 Million USD. See operational self-sufficiency of Briacell Therapeutics Corp to measure how many days the company can operate on defensive assets alone.
Annual Long-term Investment Intensity for Briacell Therapeutics Corp (2017–2024)
The table below presents the year-by-year Long-term Investment Intensity for Briacell Therapeutics Corp from 2017 to 2024, covering 8 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Briacell Therapeutics Corp total assets.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 5.1% | $418.49K | $8.15 Million | ▲ +5.1 pp |
| 2023 | 0.0% | $2.00 | $36.28 Million | ▲ +0.0 pp |
| 2022 | 0.0% | $2.00 | $54.60 Million | ▲ +0.0 pp |
| 2021 | 0.0% | $2.00 | $72.54 Million | ▼ 0.0 pp |
| 2020 | 0.0% | $2.00 | $522.33K | ▼ 0.0 pp |
| 2019 | 0.0% | $2.00 | $444.66K | ▲ +0.0 pp |
| 2018 | 0.0% | $2.00 | $2.28 Million | ▼ 0.0 pp |
| 2017 | 0.0% | $2.00 | $1.64 Million | — |